INBS 8-K: SEC filing
Filed with the SEC on · accession 0001493152-26-050982
INBS filed a 8-K (current report) with the SEC on Nov 10, 2026. A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more. The stock moved -1.7% by the first close after the filing.
Summary of the filing
Intelligent Bio Solutions Inc. furnished a press release announcing its financial results for the first quarter of fiscal 2027 ended September 30, 2026.
Key details
How INBS stock reacted
Close before
$2.29
Nov 9, 2026
First close after
-1.75%
$2.25
5 trading days
—
Since filing
—
✦ Ask GOAX AI about this filing — what it means for INBS, what changed since its last filings and what to watch next.
Try it free for 7 days🔔 Want to stay updated on new SEC filings for INBS?
Click hereFrequently asked questions
What did INBS file with the SEC on Nov 10, 2026?
INBS filed a 8-K (SEC filing). Intelligent Bio Solutions Inc. furnished a press release announcing its financial results for the first quarter of fiscal 2027 ended September 30, 2026.
How do I read a 8-K?
A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more. The "Item" number tells you the topic (e.g. 2.02 results, 5.02 executive change, 1.01 new agreement, 1.03 bankruptcy). Exhibits (99.1 press release) usually hold the details.
Why are SEC filings important?
Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A 8-K (current report): A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more.
How did INBS stock react to this filing?
INBS closed at $2.29 before the filing and $2.25 on Nov 10, 2026 (-1.75%).
Other INBS SEC filings
- 10-Q · SEC filingNov 10, 2026
- DEF 14A · SEC filingNov 2, 2026
- 10-K/A · RestatementOct 21, 2026
- 8-K · SEC filingOct 13, 2026
- 424B3 · Secondary offeringSep 23, 2026
- EFFECT · SEC filingSep 23, 2026
- S-3 · Shelf registrationSep 15, 2026
- 8-K · SEC filingSep 11, 2026
- 8-K · Fda approvalSep 9, 2026
- 8-K · Secondary offeringSep 2, 2026
Get alerts when INBS files with the SEC, plus live charts, key levels and news for 13,000+ stocks.
Try SEPT free for 7 days